ABSTRACT Sphingolipids are highly bioactive compounds that participate in the regulation of cell growth, differentiation, diverse cell functions, and apoptosis. They are present in both plant and animal foods in appreciable amounts, but little is known about their nutritional significance. Recent studies have shown that feeding sphingomyelin to female CF1 mice treated with a colon carcinogen (1,2-dimethylhydrazine) reduced the number of aberrant colonic crypt foci; longer-term feeding also affected the appearance of colonic adenocarcinomas. Therefore, dietary sphingolipids should be considered in studies of the relationships between diet and cancer. Sphingolipids have also surfaced as important factors in understanding the mechanism of action of a recently discovered family of mycotoxins, termed fumonisins. Fumonisins are produced by fungi commonly found on maize and a few related foods, and their consumption can result in equine leukoencephalomalacia, porcine pulmonary edema and a number of other diseases of veterinary animals and, perhaps, humans. A cellular target of fumonisins is the enzyme ceramide synthase, and disruption of sphingolipid metabolism by fumonisins has been established by studies with both cells in culture and animals that have consumed these toxic mycotoxins. These findings underscore the ways in which sphingolipids and agents that affect sphingolipid utilization should be given consideration in selecting animal diets for nutritional and toxicological studies.
Sphingolipids are the most structurally diverse class of memg for pork, beef and chicken (Blank et al. 1992 ) to approxibrane lipids, being composed of over 70 long-chain (sphingoid) mately 1 mmol/g for milk, butter and cheese (Jensen and Newbases, dozens of amide-linked fatty acids, and more than 300 burg 1995). Sphingolipids are not ''essential'' nutrients and headgroups. The structures of representative sphingolipids are provide few calories; nonetheless, recent studies have uncovshown in Figure 1 (for a more detailed introduction to sphinered ways in which they are nutritionally significant as highly golipids, see Merrill and Sweeley 1996) . Sphingolipids are presbioactive components of food, and a number of mycotoxins ent in all eukaryotic and some prokaryotic organisms, but there of agricultural importance act via disruption of sphingolipid have been relatively few analyses of the amounts and types in metabolism. food. Fruits and vegetables contain from°0.1 mmol/g fresh weight (for apples) (Hitchcock and Nichols 1971) to approxi-FUNCTIONS OF SPHINGOLIPIDS mately 2 mmol/g dry weight (for soybeans) (Ohnishi and Fujino 1982) ; most of the sphingolipids in plants are cerebrosides, Sphingolipids are both structural and functional lipids. whereas ceramide phosphoinositols are the predominant comTheir physical properties (such as high phase transition tempounds in yeast. Foods of animal origin contain sphingomyelin peratures) affect the properties of membranes and lipoproteins, and glycosphingolipids with both simple and complex carbohyand they are critical components of the water barrier of skin. drate headgroups; typical amounts range from 0.3 to 0.5 mmol/ They serve as ligands for extracellular matrix proteins and receptors on neighboring cells, as well as for enteric bacteria factor-a, interleukin-1b, nerve growth factor and 1a,25-dihy- 
831S SPHINGOLIPIDS AND ANALOGS IN ANIMAL DIETS

FACTORS THAT ALTER SPHINGOLIPID METABOLISM: FUMONISINS AND OTHER MICROBIAL INHIBITORS OF SPHINGOLIPID METABOLISM
Fumonisins are mycotoxins produced by Fusarium moniliforme and related fungi that are prevalent on corn, sorghum, millet and other agricultural products (Bezuidenhout et al. 1988) . They cause a number of diseases of animals, including equine leukoencephalomalacia, porcine pulmonary edema, renal toxicity, hepatotoxicity and hepatocarcinogenicity in rats, and consumption of contaminated maize has been correlated with esophageal cancer in areas of southern Africa and China (for a review see Riley et al. 1994) .
The enzyme ceramide synthase is a major cellular target Merrill et al. 1996 , Riley et al. 1996 .
eramide (GalGluCer), and ganglioside G M3 (N-acetylneuraminic acidgalactosyl-glucosyl-ceramide).
Studies of various animals (including ponies, pigs and rats) have established that fumonisins also disrupt sphingolipid metabolism in vivo and that an elevation of sphinganine in cause they seem to be key players in the regulation of cell urine, serum and tissues can be used as a biomarker for growth, differentiation and apoptosis. For a brief overview of exposure (Riley et al. 1994) . sphingolipid metabolism and some of the signaling pathways, Because many of the natural composition diets fed to laborasee Figure 2 .
tory animals potentially contain fumonisins, we were curious to know whether this biomarker would be affected by the
DIETARY SPHINGOLIPIDS AND COLON CARCINOGENESIS
Dietary sphingolipids are hydrolyzed throughout the small and large intestine to the same bioactive compounds (e.g., sphingosine and ceramide) that are used as second messengers by cells (Fig. 2) (Schmelz et al. 1994) . These compounds might be harmful to the gastrointestinal tract; however, a recent study in which mice were fed sphingomyelin observed no deleterious effects on the gastrointestinal tract or on weight gain (Dillehay et al. 1994) . Instead, the feeding of sphingomyelin to female CF1 mice that had been treated with 1,2-dimethylhydrazine to induce colon tumors caused a significant reduction in the appearance of aberrant colonic crypts, an early marker of colon carcinogenesis, and decreased the appearance of adenocarcinomas (Dillehay et al. 1994) . The levels of sphingomyelin that were used in these studies (0.025-0.1% of the diet, wt/wt) were comparable to that of the source from which the sphingomyelin was isolated (milk) (Zeisel et al. 1986 ); therefore, the findings indicate that dietary sphingolipids could play a role in colon carcinogenesis. If so, sphingolipids might account for some of the current confusion regarding the agents in foods that account for the relationships between diet and cancer.
It warrants comment that one might raise a similar concern about studies with experimental animals because many defined diets contain ''unnaturally'' low amounts of sphingolipids. For example, the AIN-76A diet contains very little sphingolipid (i.e., õ0.005%) because the components (casein, corn oil, sucrose, starch, etc.) are essentially sphingolipid free (Dillehay et al. 1994) . This is probably the case also for other diets composed of purified protein, carbohydrates and many plant et al. 1986) . It is likely that many more functions would be known if these compounds were not so difficult to obtain in the amounts necessary for nutritional studies.
SUMMARY AND PERSPECTIVES FOR THE FUTURE
The selection of diets for experimental animals should take into account the fact that sphingolipids are usually found in food and that, although their roles in normal physiology and disease are only beginning to emerge, they have potent biological activities that are likely to make them relevant to nutrition. In addition, now that we know that diets are often contaminated with agents that alter sphingolipid metabolism, this should be factored into the interpretation of long-term feeding studies.
It is possible that some of the difficulties in extrapolating nutritional findings with model systems to more complex diets have been due to lack of consideration of the roles played by dietary sphingolipids. One is lead to wonder whether, in addition to colon cancer, there are other diseases (of the gastroin- reflected by this biomarker. The P value represents the significance of 743-745. this linear regression fit to the data. There are a few additional ways that the sphingolipids in 
